These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 1356154

  • 1. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B, Grigoriadis DE, DeSouza EB.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [Abstract] [Full Text] [Related]

  • 2. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B, Grigoriadis DE, DeSouza EB.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [Abstract] [Full Text] [Related]

  • 3. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
    Levant B, DeSouza EB.
    Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
    [Abstract] [Full Text] [Related]

  • 4. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P, Olianas MC, Gessa GL.
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [Abstract] [Full Text] [Related]

  • 5. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 6. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 7. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
    Huo T, Healy DP.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):424-8. PubMed ID: 1830902
    [Abstract] [Full Text] [Related]

  • 8. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [Abstract] [Full Text] [Related]

  • 9. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
    Levant B, Moehlenkamp JD, Morgan KA, Leonard NL, Cheng CC.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):145-53. PubMed ID: 8764345
    [Abstract] [Full Text] [Related]

  • 10. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 11. Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain.
    Gehlert DR, Gackenheimer SL, Seeman P, Schaus J.
    Eur J Pharmacol; 1992 Feb 11; 211(2):189-94. PubMed ID: 1351846
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG, Cotterell DJ, Dubocovich ML.
    J Pharmacol Exp Ther; 1987 Dec 11; 243(3):857-67. PubMed ID: 2961878
    [Abstract] [Full Text] [Related]

  • 13. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT, Dickman M.
    Invest Ophthalmol Vis Sci; 1992 Apr 11; 33(5):1620-6. PubMed ID: 1532792
    [Abstract] [Full Text] [Related]

  • 14. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK.
    Mol Pharmacol; 1988 Apr 11; 33(4):402-13. PubMed ID: 3357484
    [Abstract] [Full Text] [Related]

  • 15. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 11; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 16. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    Mottola DM, Brewster WK, Cook LL, Nichols DE, Mailman RB.
    J Pharmacol Exp Ther; 1992 Jul 11; 262(1):383-93. PubMed ID: 1352553
    [Abstract] [Full Text] [Related]

  • 17. Quantitative autoradiography of Gpp(NH)p sensitive and insensitive [3H]quinpirole binding sites in the rat brain.
    Gehlert DR.
    Synapse; 1993 Jun 11; 14(2):113-20. PubMed ID: 8101393
    [Abstract] [Full Text] [Related]

  • 18. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB, Guan JH, Neumeyer JL, Seeman P.
    Mol Pharmacol; 1985 Feb 11; 27(2):193-9. PubMed ID: 3969068
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptors labelled by [3H]quinpirole.
    Seeman P, Schaus JM.
    Eur J Pharmacol; 1991 Oct 02; 203(1):105-9. PubMed ID: 1686763
    [Abstract] [Full Text] [Related]

  • 20. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
    Robinson SW, Jarvie KR, Caron MG.
    Mol Pharmacol; 1994 Aug 02; 46(2):352-6. PubMed ID: 7915820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.